![XTAMPZA](https://dev.collegiumpharma.com/wp-content/uploads/product-logo-xtampza.png)
New Important Safety Information
See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and other serious risks at XtampzaER.com/PI.
![Belbuca](https://dev.collegiumpharma.com/wp-content/uploads/product-logo-belbuca-website-e1659640751508.jpg)
New Important Safety Information
See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and Other Serious Risks at Belbuca.com/#isi-block.
![NUCYNTA ER](https://dev.collegiumpharma.com/wp-content/uploads/product-logo-nucynta-er.png)
New Important Safety Information
See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and other serious risks at Nucynta.com/erPI.
![NUCYNTA](https://dev.collegiumpharma.com/wp-content/uploads/product-logo-nucynta.png)
New Important Safety Information
See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and other serious risks at Nucynta.com/irPI.
![SYMPROIC](https://dev.collegiumpharma.com/wp-content/uploads/product-logo-symproic-website-e1659640567867.jpg)
Important Safety Information
See full Important Safety Information and Other Serious Risks at Symproic.com/#isi.
XTAMPZA® and NUCYNTA® and BELBUCA® are registered trademarks. SYMPROIC® is a registered trademark of Shionogi, Inc.
© 2024 Collegium Pharmaceutical, Inc. All rights reserved.